the market?
ENTREMED, INC.
NASDAQ: ENMD
1.77
-0.01
(-0.56%)
| Today's Open | $1.76 |
|---|---|
| Previous Close | $1.78 |
| Daily Range | $1.76 - $1.77 |
| 52-Week Range | $1.23 - $3.73 |
| Market Cap | $47.8M |
| P/E Ratio | -2.97 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 7,711 |
| Average Daily Volume | 47,438 |
| Current FY EPS | $0.00 |
How do you think ENMD
will perform against the market?
Top ENMD Bull/Bear Pitches
ShuntSD (< 20)
Submitted
October 20, 2006
As others say, a gamble with huge upside. But the small molecule research is promising and acquisition was a nice move. Keep close eye on it with stops.
hlacheen (< 20)
Submitted
December 22, 2006
Just look at the income statement and cash flow.... this company is a cash-burning disaster, it is NOT worth $120m
News & Commentary
24/7 Wall St. Closing Bell — November 26, 2012: Markets Open Low, Closed Mixed (MCD, YHOO, FB, BHP,
24/7 Wall St. Closing Bell — November 26, 2012: Markets Open Low, Closed Mixed (MCD, YHOO, FB, BHP, DE, ADT, RAH, KCG, MMR, ENMD)Stock Downgrades: Bank of Ireland Struggles to Stay in Green
Wall Street ratings agencies set the tone for today's stock market.10 Biotechs Targeting Cancer Stem Cell Destruction
Here, a partial list of emerging public companies with programs that take a novel approach to eradicating cancer.The Best Stocks for the Next 4 Years
Get in while the gettin' is good.Sector
Healthcare
Industry
Drugs
ENTREMED, INC. (ENMD) Description
A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. Website: http://www.entremed.com/
